MUTUAL FUND SERIES TRUST's Eventide Healthcare & Life Sciences Fund (ETAHX) has disclosed 55 total holdings in their latest N-PORT filing with the SEC for the
portfolio date of 2025-03-31. The current portfolio value is calculated to be $1.00 Bil, only including common equities, preferred
equities, ETFs, options and warrants for equities. The turnover rate is 11%.
Eventide Healthcare & Life Sciences Fund (ETAHX)'s
Total Assets is $1.13 Bil , Total Liabilities is $13.86 Mil , Net Assets is $1.12 Bil.
In Eventide Healthcare & Life Sciences Fund (ETAHX)'s current portfolio as of 2025-03-31, the top 5 holdings are
Verona Pharma PLC (VRNA), Insmed Inc (INSM), Guardant Health Inc (GH), Mirum Pharmaceuticals Inc (MIRM) and Axsome Therapeutics Inc (AXSM),
not including call and put options.
Eventide Healthcare & Life Sciences Fund (ETAHX) did not buy any new stocks in the current portfolio.
Please visit the "Current Portfolio" tab to see the mutual fund's current and past N-PORT holdings for Eventide Healthcare & Life Sciences Fund (ETAHX), as well as holding map,
valuations for each stock, which positions are undervalued, have low PE Ratios, are considered high quality and recently traded at 52-week lows, etc.
Please visit the "Stock Picks" tab to see the mutual fund's latest trades and stock picks for Eventide Healthcare & Life Sciences Fund (ETAHX), which include data from form N-PORT.
Please visit the "Summary" page to see the top 10 holdings, recent stock picks, performance, sector / industry breakdown details, as well as past holding history summary for Eventide Healthcare & Life Sciences Fund.